Canada markets close in 2 hours 55 minutes

Xeno Transplants Corporation (XENO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
As of 01:55PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 363.27k
Enterprise Value 363.27k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)10.92
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.72

Trading Information

Stock Price History

Beta (5Y Monthly) -26.79
52-Week Change 30.00%
S&P500 52-Week Change 321.23%
52 Week High 30.0001
52 Week Low 30.0001
50-Day Moving Average 30.0001
200-Day Moving Average 30.0001

Share Statistics

Avg Vol (3 month) 3357
Avg Vol (10 day) 3N/A
Shares Outstanding 5N/A
Implied Shares Outstanding 6645.82M
Float 8N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22.5:1
Last Split Date 3Sept 06, 2006

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2007
Most Recent Quarter (mrq)Mar 31, 2008


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-256.37k
Diluted EPS (ttm)-0.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)261
Total Cash Per Share (mrq)0
Total Debt (mrq)502.23k
Total Debt/Equity (mrq)1,509.20%
Current Ratio (mrq)0.15
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-258.06k
Levered Free Cash Flow (ttm)N/A